These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7672436)

  • 1. Might environmental factors contribute to neurodegenerative diseases?
    Tipton KF
    Biochem Soc Trans; 1995 May; 23(2):429-35. PubMed ID: 7672436
    [No Abstract]   [Full Text] [Related]  

  • 2. MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease.
    Furtado JC; Mazurek MF
    Can J Neurol Sci; 1991 Feb; 18(1):77-82. PubMed ID: 2036621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial mechanisms of neurotoxicity.
    Nicklas WJ; Saporito M; Basma A; Geller HM; Heikkila RE
    Ann N Y Acad Sci; 1992 May; 648():28-36. PubMed ID: 1637057
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease.
    Zigmond MJ; Hastings TG; Abercrombie ED
    Ann N Y Acad Sci; 1992 May; 648():71-86. PubMed ID: 1637074
    [No Abstract]   [Full Text] [Related]  

  • 5. The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disorders.
    Pollard HB; Adeyemo M; Dhariwal K; Levine M; Caohuy H; Markey S; Markey CJ; Youdim MB
    Ann N Y Acad Sci; 1993 May; 679():317-20. PubMed ID: 8512193
    [No Abstract]   [Full Text] [Related]  

  • 6. In search of the causes of Parkinson's disease, seasons 1 to 4.
    Elbaz A
    Eur J Epidemiol; 2011 Jul; 26(7):505-9. PubMed ID: 21626392
    [No Abstract]   [Full Text] [Related]  

  • 7. Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses.
    Trojanowski JQ
    Exp Neurol; 2003 Jan; 179(1):6-8. PubMed ID: 12504862
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic and environmental factors in the pathogenesis of Parkinson's disease.
    Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T
    Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718
    [No Abstract]   [Full Text] [Related]  

  • 9. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?
    Spencer PS; Ludolph AC; Kisby GE
    Ann N Y Acad Sci; 1992 May; 648():154-60. PubMed ID: 1322079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
    Willets JM; Lunec J; Williams AC; Griffiths HR
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):299S. PubMed ID: 8224447
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic administration of MPTP to marmosets.
    Albanese A; Altavista MC; Gozzo S; Rossi P; Colosimo C; Bentivoglio AR; Perretta G; Elia M; Monaco V; Macchi G
    Adv Neurol; 1990; 53():239-44. PubMed ID: 1978517
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice.
    Nagatsu T
    Adv Neurol; 1990; 53():207-14. PubMed ID: 1978515
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine.
    Sonsalla PK; Giovanni A; Sieber BA; Donne KD; Manzino L
    Ann N Y Acad Sci; 1992 May; 648():229-38. PubMed ID: 1637048
    [No Abstract]   [Full Text] [Related]  

  • 15. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPTP and other Parkinson-inducing agents.
    Schapira AH
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):396-400. PubMed ID: 1623269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MPTP and amphetamines as dopaminergic neurotoxins.
    Fuller RW
    Ann N Y Acad Sci; 1992 May; 648():87-95. PubMed ID: 1637075
    [No Abstract]   [Full Text] [Related]  

  • 18. Features of the dopaminergic neurotoxin MPTP.
    Kopin IJ
    Ann N Y Acad Sci; 1992 May; 648():96-104. PubMed ID: 1637076
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotoxicity of an MPTP analogue, 2'CH3-MPTP, on monoaminergic systems in the mouse brain.
    Gupta M; Chen XL
    Ann N Y Acad Sci; 1992 May; 648():283-5. PubMed ID: 1353331
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?
    Shaw CA; Höglinger GU
    Neuromolecular Med; 2008; 10(1):1-9. PubMed ID: 17985252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.